HIV Articles  
Back 
 
 
Bioavailability of Efavirenz Capsule Contents (Sprinkles) Mixed with a Small Amount of Food Compared with Intact Capsules in Healthy Adults
 
 
  Reported by Jules Levin
1st International Workshop on HIV Pediatrics -
Cape Town, South Africa - July 17 - 18, 2009
 
S. Kaul, P. Ji*, M. Lu*, D. Seekins, K. L. Nguyen, T. Shangguan, D. Grasela Bristol-Myers Squibb Research and Development, Princeton, NJ USA This study was sponsored by Bristol-Myers Squibb
 
AUTHOR CONCLUSIONS
 
The AUC of EFV capsule contents mixed with these food vehicles was bioequivalent to the intact capsule formulation administered under fasted conditions
 
All treatments were generally safe and well tolerated
 
Grape jelly was the most palatable food vehicle
 
These data suggest that EFV capsule contents may be administered with a small amount (2 teaspoons) of applesauce, grape jelly, yogurt, or infant formula

backgroud-1.gif

methods-2.gif

hands-3.gif

pm-4.gif

cross-5.gif

deom-6.gif

ABC-7.gif

Oral-8.gif

grp-9.gif

group-10.gif

forGroup-11.gif

table2-12.gif

figure-13.gif

Tremnt-14.gif

more-15.gif

events-16.gif

REFERENCES
 
1. Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv. 2007;4:37-45.
2. Sustiva (efavirenz) capsules and tablets package insert. Princeton, NJ: Bristol-Myers Squibb Company; 2009 March.
3. Sustiva (efavirenz) summary of product characteristics. Uxbridge, United Kingdom: Bristol-Myers Squibb Pharmaceuticals Ltd; 2008 August.
 
 
 
 
  iconpaperstack view older Articles   Back to Top   www.natap.org